Correlation Between Oramed Pharmaceuticals and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Oramed Pharmaceuticals and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oramed Pharmaceuticals and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oramed Pharmaceuticals and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Oramed Pharmaceuticals and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oramed Pharmaceuticals with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oramed Pharmaceuticals and Crinetics Pharmaceuticals.
Diversification Opportunities for Oramed Pharmaceuticals and Crinetics Pharmaceuticals
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Oramed and Crinetics is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Oramed Pharmaceuticals and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Oramed Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oramed Pharmaceuticals are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Oramed Pharmaceuticals i.e., Oramed Pharmaceuticals and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Oramed Pharmaceuticals and Crinetics Pharmaceuticals
Given the investment horizon of 90 days Oramed Pharmaceuticals is expected to under-perform the Crinetics Pharmaceuticals. In addition to that, Oramed Pharmaceuticals is 1.16 times more volatile than Crinetics Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about 0.06 per unit of volatility. If you would invest 4,644 in Crinetics Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 1,076 from holding Crinetics Pharmaceuticals or generate 23.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oramed Pharmaceuticals vs. Crinetics Pharmaceuticals
Performance |
| Timeline |
| Oramed Pharmaceuticals |
| Crinetics Pharmaceuticals |
Oramed Pharmaceuticals and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oramed Pharmaceuticals and Crinetics Pharmaceuticals
The main advantage of trading using opposite Oramed Pharmaceuticals and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oramed Pharmaceuticals position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.| Oramed Pharmaceuticals vs. Protalix Biotherapeutics | Oramed Pharmaceuticals vs. Corvus Pharmaceuticals | Oramed Pharmaceuticals vs. Aldeyra | Oramed Pharmaceuticals vs. Checkpoint Therapeutics |
| Crinetics Pharmaceuticals vs. DiaMedica Therapeutics | Crinetics Pharmaceuticals vs. Lyra Therapeutics | Crinetics Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |